COMPARISON OF INVITRO AND INVIVO EFFECTS OF PRAZOSIN ON LIPID-METABOLISM

被引:35
作者
KATHER, H
SAUBERLICH, P
机构
关键词
D O I
10.1016/0002-9343(84)90962-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:89 / 93
页数:5
相关论文
共 15 条
[1]   ALPHA-ADRENERGIC RECEPTOR BLOCKADE WITH PRAZOSIN - CONSIDERATION OF HYPERTENSION, HEART-FAILURE, AND POTENTIAL NEW APPLICATIONS [J].
COLUCCI, WS .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) :67-77
[2]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[3]   HUMAN FAT-CELL ADENYLATE-CYCLASE - REGIONAL DIFFERENCES IN ADRENALINE RESPONSIVENESS [J].
KATHER, H ;
ZOLLIG, K ;
SIMON, B ;
SCHLIERF, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (06) :595-597
[4]  
KATHER H, 1982, J CARDIOVASC PHARM, V4, pS245
[5]  
KATHER H, P SERONO S LUMINESCE
[6]  
KATHER H, 1981, TRIANGLE, V20, P131
[7]   PRAZOSIN AND CLONIDINE FOR MODERATELY SEVERE HYPERTENSION [J].
KIRKENDALL, WM ;
HAMMOND, JJ ;
THOMAS, JC ;
OVERTURF, ML ;
ZAMA, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (23) :2553-2556
[8]   EFFECT OF PRAZOSIN ON SERUM-LIPIDS [J].
KOKUBU, T ;
ITOH, I ;
KURITA, H ;
OCHI, T ;
MURATA, K ;
YUBA, I .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 :S228-S232
[9]  
LEREN P, 1982, J CARDIOVASC PHARM, V4, pS222
[10]  
LEREN P, 1980, LANCET, V2, P4